In conclusion, our results provide the idea that NBR1 is downregulated in ccRCC tissues, renal cancer cell lines and their sunitinib-resistant cells and identified as an new independent predictor for prognosis in ccRCC patients. The gene discussed is NBR1; the disease is renal carcinoma.